Nomogram for predicting recurrence in stage II colorectal cancer

Abstract

Our nomogram can be a useful tool for accurate prediction of recurrence in stage II colorectal cancer.

Trends in presentation, treatment and survival of 1777 patients with colorectal cancer over a decade: a Biobank study

“…Half of the patients with rectal cancer had received preoperative radiotherapy, which could have resulted in eradication of lymph node metastases, and, therefore, affecting these results. A poorer prognosis for right-sided than left-sided colon cancer has been shown in stage IV CRC [25], but in stage I-III disease conflicting results are reported [26][27][28]. Right-sided colon cancer has been associated with poor differentiation grade and T4 stage, but is less likely to be node-positive, than left-sided colon cancer [27].…”

Need for adjuvant chemotherapy after colon cancer surgery – has it decreased?

“…In a preceding issue of Acta Oncologica, Hoshino et al [7] similarly found the pronounced influence of infiltration depth. Their study created a nomogram to predict the probability of recurrence in stage II CRC, not separating colon and rectal cancer.…”

What is most relevant in preoperative rectal cancer chemoradiotherapy – the chemotherapy, the radiation dose or the timing to surgery?

“…Besides the three articles about radiation therapy in rectal cancer discussed above [22,42,43], another five articles in this issue of Acta Oncologica also deal with colorectal cancer [49][50][51][52][53]. Four of them concern the prognosis of early stage colorectal cancer, also a very important topic where great uncertainties about which patients should be given adjuvant chemotherapy exist.…”